Y0001832

イリノテカン 一塩酸塩 三水和物

European Pharmacopoeia (EP) Reference Standard

• 別名: Irinotecan monohydrochloride trihydrate, [1,4′-Bipiperidine]-1′-carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester monohydrochloride trihydrate
• 実験式（ヒル表記法）: C₃₃H₃₈N₄O₆ · HCl · 3H₂O
• CAS番号: 136572-09-3
• 分子量: 677.18
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: irinotecan
• 保管温度: 2-8°C
• SMILES記法: [Cl-].N21Cc3c(nc5c(c3CC)cc(cc5)OC(=O)N6CCC(CC6)N7CCCCC7)C2=CC4=C(COC(=O)[C@]4(O)CC)C1=O.O.O.O.[H+]
• InChI: 1S/C33H38N4O6.ClH.3H2O/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;;;;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H;3*1H2/t33-;;;;/m0..../s1
• InChI Key: KLEAIHJJLUAXIQ-JDRGBKBRSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 170 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302
• 注意書き: P301 + P312 + P330
• 危険有害性の分類: Acute Tox. 4 Oral
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable